Suppr超能文献

单纯甲状腺全切除术治疗低危分化型甲状腺癌患者的长期预后。

Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone.

机构信息

Unit of Endocrinology, Department of Clinical and Experimental Medicine, Pisa University Hospital, 56124 Pisa, Italy.

Pathology Unit 3, Department of Surgical, Medical, Molecular Pathology and Critical Area, Pisa University Hospital, 56124 Pisa, Italy.

出版信息

Curr Oncol. 2024 Sep 16;31(9):5528-5536. doi: 10.3390/curroncol31090409.

Abstract

BACKGROUND

Differentiated thyroid carcinoma (DTC), mainly papillary (PTC), at low risk of recurrence is currently managed with active surveillance strategies or less aggressive surgeries. However, total thyroidectomy with I treatment is still performed both if these tumors are diagnosed before or occasionally after surgery. This real-life study aimed to evaluate the rate of biochemical, structural, and functional events in a large series of consecutive DTCs at low risk of recurrence treated by total thyroidectomy, but not with I, in a medium-long-term follow-up.

PATIENTS AND METHODS

We evaluated clinical-pathologic data of 383 consecutive patients (2006-2012) with unifocal DTC [T1a/b(s)] at low risk of recurrence, treated with total thyroidectomy but without lymph node dissection and I treatment after surgery. We evaluated if structural, biochemical, and functional events were detected during the follow-up.

RESULTS

Females accounted for 75.7% of our study group, and the median age was 50 years. The median tumor dimension was 0.4 cm (range 0.1-1.2). Most of the patients had a unifocal T1a tumor (98.9%), and 73.6% had a classic variant of PTC. We divided the patients according to the absence (group A-n = 276) or presence (group B-n = 107) of interfering TgAb at first control after surgery. After a median follow-up of 10 years, no structural events were detected. Sixteen out of three hundred and eighty-three (4.2%) patients developed biochemical events: 12/276 (4.3%) in group A and 4/107 (3.7%) in group B. The median time elapsed from surgery to detecting a biochemical event was 14.5 and 77.5 months in groups A and B, respectively. No patients performed additional treatments and were followed up with an active surveillance strategy.

CONCLUSIONS

This study confirmed that patients with DTC at low risk of recurrence showed an excellent outcome in a medium long-term follow-up since no structural events were diagnosed. Significant variations in Tg/TgAb were detected in a few cases, all managed with an active surveillance strategy without the need for other treatments. Therefore, a relaxed follow-up with neck ultrasound and Tg/TgAb measurement is enough to early identify those very unusual cases of recurrence.

摘要

背景

分化型甲状腺癌(DTC),主要是乳头状癌(PTC),复发风险低,目前采用主动监测策略或侵袭性较小的手术进行治疗。然而,即使这些肿瘤在术前或术后偶尔被诊断出来,也仍会进行全甲状腺切除术和 I 治疗。本真实世界研究旨在评估在中长期随访中,对一组接受全甲状腺切除术但未接受 I 治疗的低复发风险连续 DTC 患者进行评估。

患者和方法

我们评估了 383 例连续患者(2006-2012 年)的临床病理数据,这些患者患有单发低危 DTC[T1a/b(s)],接受了全甲状腺切除术,但术后未进行淋巴结清扫和 I 治疗。我们评估了在随访过程中是否检测到结构、生化和功能事件。

结果

女性占研究组的 75.7%,中位年龄为 50 岁。肿瘤的中位直径为 0.4cm(范围 0.1-1.2cm)。大多数患者为单发 T1a 肿瘤(98.9%),73.6%为经典型 PTC。我们根据手术后首次检查时是否存在(A 组,n=276)或不存在(B 组,n=107)干扰性 TgAb 将患者分为两组。在中位随访 10 年后,未发现结构事件。383 例患者中有 16 例(4.2%)发生生化事件:A 组 12/276(4.3%),B 组 4/107(3.7%)。A 组和 B 组从手术到检测到生化事件的中位时间分别为 14.5 和 77.5 个月。没有患者进行额外治疗,采用主动监测策略进行随访。

结论

本研究证实,在中长期随访中,低复发风险的 DTC 患者的预后良好,因为未诊断出结构事件。在少数情况下,Tg/TgAb 有显著变化,所有患者均采用主动监测策略进行管理,无需其他治疗。因此,通过颈部超声和 Tg/TgAb 测量进行宽松的随访足以早期识别那些非常罕见的复发病例。

相似文献

本文引用的文献

5
COVID-induced thyroid autoimmunity.新冠病毒感染诱发的甲状腺自身免疫
Best Pract Res Clin Endocrinol Metab. 2023 Mar;37(2):101742. doi: 10.1016/j.beem.2023.101742. Epub 2023 Feb 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验